<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CITA
BIOMEDICAL, INC. UNAUDITED BALANCE SHEET AS OF JUNE 30, 2000 AND THE RELATED
STATEMENT OF INCOME FOR THE THREE AND SIX MONTHS THEN ENDED AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 10,386
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 10,386
<PP&E> 58,311
<DEPRECIATION> 40,437
<TOTAL-ASSETS> 927,057
<CURRENT-LIABILITIES> 1,336,293
<BONDS> 0
0
896,444
<COMMON> 77,667
<OTHER-SE> (1,383,347)
<TOTAL-LIABILITY-AND-EQUITY> 927,057
<SALES> 212,891
<TOTAL-REVENUES> 212,891
<CGS> 142,475
<TOTAL-COSTS> 593,617
<OTHER-EXPENSES> (226)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (380,500)
<INCOME-TAX> 0
<INCOME-CONTINUING> (380,500)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (380,500)
<EPS-BASIC> (0.05)
<EPS-DILUTED> (0.05)
</TABLE>
